NCT03468582View on ClinicalTrials.gov

123I Radiolabeled 3BNC117

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 8, 2018

Primary Completion Date

January 28, 2020

Study Completion Date

January 28, 2020

Conditions
Human Immunodeficiency Virus
Interventions
COMBINATION_PRODUCT

123I radiolabeled 3BNC117

123I radiolabeled 3BNC117

Trial Locations (1)

1011

Centre Hospitalier Universitaire Vaudois, Lausanne

All Listed Sponsors
lead

University of Lausanne Hospitals

OTHER

NCT03468582 - 123I Radiolabeled 3BNC117 | Biotech Hunter | Biotech Hunter